HEMOPHILIA OF GEORGIA INC (EIN 581175625) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1973

Legal Domicile

Principal Officer

ROBERT GILLESPIE

Phone

7705188272

Tax Period

2022-07-01 to 2023-06-30

HEMOPHILIA OF GEORGIA INC, founded in 1973, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $28.7M in total revenue in fiscal year 2022. Expenses of $24.6M left a modest 14% surplus.

Mission

HEMOPHILIA OF GEORGIA EXISTS SO THAT PEOPLE IN GEORGIA AFFECTED BY BLEEDING DISORDERS LIVE AS NORMALLY AND PRODUCTIVELY AS POSSIBLE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $1,567,368

Program Service Revenue $493,292

Investment Income $929,001

Other Revenue $25,684,688

TOTAL REVENUE $28,674,349

Expense Breakdown

Grants Paid $9,182,200

Salaries & Benefits $9,797,725

Fundraising Expenses $989,442

Program Expenses $20,964,668

Other Expenses $5,610,196

TOTAL EXPENSES $24,590,121

Year-over-Year Comparison

	2022	2021	Change
Revenue	$28,674,349	$26,727,211	+0.1%
Expenses	$24,590,121	$21,684,437	+0.1%
Net Income	$4,084,228	$5,042,774	-0.2%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

127

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$981,431

Total Directors

Key Employees

$237,702

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EDITH A ROSATO	CEO	40.00	Officer	$537,018	$38,053	$575,071
PAUL PERROTTI	CFO	40.00	Officer	$358,162	$48,198	$406,360
LEIGH CARPENTER	VP OF PHARMACY OPERATIONS	40.00	Highest	$218,063	$32,503	$250,566
ROBERT GILLESPIE	VP OF PROGRAMS	40.00	Key Emp	$209,033	$28,669	$237,702
VICTOR MCCARTHY	CHIEF DEVELOPMENT OFFICER	40.00	Highest	$199,660	$26,890	$226,550
MARK JOLLY	VP PAYER RELATIONS & NETWORK DEVELOP	40.00	Highest	$188,357	$31,885	$220,242
KAREN GENEY	CHIEF OPERATING OFFICER	40.00	Highest	$171,960	$17,093	$189,053
JACKIE SHIPP	VP INFORMATION TECHNOLOGY	40.00	Highest	$178,294	$9,577	$187,871
DAVID BURNS	CHIEF GOVERNANCE OFFICER	1.00	Officer Director	$0	$0	$0
TODD RATLIFF	SECRETARY/DIRECTOR	1.00	Officer Director	$0	$0	$0
TOM BRAND	DIRECTOR	0.50	Director	$0	$0	$0
DAN MADDOCK	DIRECTOR	0.50	Director	$0	$0	$0
DR ROBERT CARTON	DIRECTOR	0.50	Director	$0	$0	$0
HIRAM ALLEN	DIRECTOR	1.00	Director	$0	$0	$0
ALEX POPE	VICE CHIEF GOVERNANCE OFFICER	1.00	Director	$0	$0	$0
RADIUM YAN	DIRECTOR	0.50	Director	$0	$0	$0
DONNEL WARREN	DIRECTOR	0.50	Director	$0	$0	$0
PAD NARAYANAN	DIRECTOR	0.50	Director	$0	$0	$0
ANDY WURTZEL	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$28,674,349	$24,590,121	$86,473,069	$4,084,228
2022	$26,727,211	$21,684,437	$77,460,536	$5,042,774
2021	$24,562,732	$19,174,195	$67,882,004	$5,388,537
2020	$12,896,401	$15,805,316	$59,043,671	$-2,908,915
2019	$24,775,164	$26,635,147	$64,363,814	$-1,859,983
2018	$24,921,423	$20,441,811	$63,354,163	$4,479,612

HEMOPHILIA OF GEORGIA INC